With US FDA Adcomm Meetings Disappearing, Sponsors Seek Other Outlets For Patient Voice

 
• By Derrick Gingery
  
FDA advisory committee meetings, including their open public hearings, have become a rare occurrence in 2025. (Screenshot of FDA Broadcast)

More from US Advisory Committees

More from United States